Bruno García del Blanco

Showing 1-6 of 6 articles

Author José Moreu

Coronary interventions

First-in-man randomized comparison of the Angiolite® durable fluoro-acrylate polymer-based sirolimus-eluting stent versus durable fluoropolymer-based everolimus eluting stent in patients with coronary artery disease: The ANGIOLITE trial

Moreu J, Moreno-Gómez R, Pérez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat I

July 16, 2019 | 10.4244/EIJ-D-19-00206

Author Bruno García del Blanco

Coronary interventions

Spain: coronary and structural heart interventions from 2010 to 2015

García del Blanco B, Jimenez-Quevedo P, Diaz J, Hernandez F, Rumoroso J-R, Sabaté M, de la Torre Hernandez J, Serrador A, Pérez de Prado A, Goicolea J, Trillo R, Pan M

May 15, 2017 | 10.4244/EIJ-D-16-00834

Author Arturo Garcia-Touchard

Coronary interventions

A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)

Garcia-Touchard A, Goicolea J, Sabaté M, Alfonso F, Ruiz-Salmeron R, Bethencourt A, Gonzalo N, Miranda F, García del Blanco B, Jimenez Mazuecos J, Melgares R, Martinez-Romero P, Hernandez-Garcia J, Lezaun R, Bullones J, Fernandez-Portales J, Rumoroso J-R, Ortas R, Valdes M, Trillo R, Brugaletta S, Otzuki S, Hernández Pérez FJ, Alonso-Pulpón L

January 20, 2017 | 10.4244/EIJ-D-16-00128

Author Fernando Alfonso

Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

Alfonso F, Perez-Vizcayno M, Cardenas A, García del Blanco B, García Touchard A, Lopez-Minguez J, Rivero F, Masotti M, Zueco J, Cequier A, Morís C, Fernandez Ortiz A, Escaned J, Jimenez-Quevedo P, Gonzalo N, Fernandez C, Macaya C

July 20, 2015 | 10.4244/EIJY14M09_07

Author Ricardo Costa

Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

Costa R, Abizaid A, Abizaid An, García del Blanco B, Berland J, Petrov I, Brenot P, van Geuns R, Royer T, Rubino P, Lesiak M, Fajadet J

March 21, 2012 | 10.4244/EIJV7I11A205

Author Bruno García del Blanco

Clinical and procedural evaluation of the Nile Croco® dedicated stent for bifurcations: a single centre experience with the first 151 consecutive non-selected patients

García del Blanco B, Martí G, Bellera N, Otaegui I, Serra V, Ferreira I, Domingo E, Angel J, Candell J, García-Dorado D

June 30, 2011 | 10.4244/EIJV7I2A36

1

Latest news

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

January 17, 2020

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke